Stock dividend issued to IMUNON shareholders reflects confidence in clinical programs, long-term growth strategy and dedication to rewarding sharehol ...

Historically, sex-related differences have been underexplored in neurology. It is important to highlight the distinction ...

Epilepsy is a serious and common neurological condition, characterised by recurring, unprovoked seizures, affecting ...

Rectal cancer chemoradiotherapy was tied to an increased risk for second nonpelvic cancers but not second pelvic cancers.

Average selling prices of Illuccix will likely decrease when its transitional pass-through payment status expires in 2025.

Breastfeeding did not appear to be associated with a higher risk of developing locoregional recurrences or contralateral breast cancers,” researchers wrote.

The findings not only demonstrate the number of legal barriers faced by various sociodemographic groups but also highlight vulnerable populations with greater need of legal navigation, informing ...

Tempus AI, Inc. TEM is scheduled to report second-quarter 2025 results on Aug. 8. In the last reported quarter, the company’s adjusted loss of 24 cents was narrower than the Zacks Consensus Estimate ...

Bristol-Myers Squibb remains a compelling Buy despite the market's over-reaction to the industry and macro headwinds. Learn ...

Background Heart auscultation is a widely used and cost-effective clinical tool for detecting valvular heart disease (VHD), ...

Adding an immune checkpoint inhibitor to neoadjuvant chemotherapy can improve pathologic complete response rates and may improve survival in patients with muscle-invasive bladder cancer, research ...

New research has revealed factors associated with an increased risk of COVID-19-related death and hospitalization among patients with cancer.